• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Azithromycin for Acute-Onset Obsessive-Compulsive Disorder in Children

Azithromycin for Acute-Onset Obsessive-Compulsive Disorder in Children

March 1, 2018
Thomas Jordan, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Thomas Jordan, MD Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Murphy et al, J Child Adolesc Psychopharmacol 2017; 27(7):640–651

Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric syndrome associated with streptococcus (PANDAS) have been the subject of many debates in the field.

From obsessions, compulsions, and tics, to personality changes and oppositional behavior, the symptoms of PANS are wide-ranging. PANDAS is considered a subset of PANS that is temporally associated with a Group A streptococcal (GAS) infection.

Due to the link to an infectious cause, antibiotics are being assessed as a treatment for PANS. This study specifically evaluated the tolerability and efficacy of azithromycin in treating children with acute onset of OCD who met criteria for PANS.

Conducted with 31 children ages 4–14, the study was a randomized, double-blind, placebo-controlled trial comparing treatment with azithromycin (10 mg/kg, up to 500 mg per day) to placebo for children with an acute onset of moderate or worse OCD symptoms and neuropsychiatric symptoms. The primary outcomes were changes in the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS), and in the Clinical Global Impression—Severity (CGI-S) scale. Several secondary outcomes were measured, including other scales for tic severity, affective lability, and anxiety. Outcome measurements were taken at baseline and then weekly for four weeks over the study period.

The results of the trial were split. The azithromycin group had a significantly greater reduction in OCD severity as measured by the CGI-S (p = 0.003) at week 4, but there was no significant difference between the treatment and control groups in the CY-BOCS scores (p = 0.203). Interestingly, the children in the azithromycin group with greater tic severity at baseline showed the most improvement in the CGI-S. For the secondary outcome measures, the only significant effect was a reduction in the Clinical Global Impression—Improvement Mood subscale (p = 0.006) in the azithromycin group.

As for side effects, the azithromycin group had significantly more loose stools (53% of treatment group vs 7% of placebo group), and the placebo group reported more constipation (36% of placebo group vs 0% of treatment group). Electrocardiograms were monitored at baseline and at week 4, showing a significant increase in the QTc (p = 0.007) for children in the azithromycin group. Four participants in the azithromycin group had a borderline QTc of 440–460 at week 4 versus 1 participant in the placebo group.

CCPR’s take
This study, along with other past trials of antibiotics for PANS, gives us mixed results. The authors postulate that the CY-BOCS may not have been the best rating tool for the younger children in this trial, leading to the less robust results compared to the CGI-S outcome. Better response to antibiotic treatment was mediated by baseline tic severity, which will need further exploration. The authors also recognize the limitations of the small study size, and view this as a pilot study that may lead to larger trials in the future. If you do embark on using azithromycin, consider baseline and follow-up electrocardiograms to watch for QTc changes.
Child Psychiatry
KEYWORDS child_psychiatry ocd research-update
    Thomas Jordan, MD

    Do Psychosocial Interventions Improve Quality of Life in Advanced Dementia?

    More from this author
    www.thecarlatreport.com
    Issue Date: March 1, 2018
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test for Anxiety - Children and Adolescents, CCPR, March/April 2018
    Negative Efficacy of Desvenlafaxine and Fluoxetine for Children and Adolescents With MDD
    Note From the Editor-in-Chief
    Benzodiazepines in Children and Adolescents
    Differentiating ADHD From Anxiety: Tips for Clinicians
    Acting Out: Is It Anxiety?
    Azithromycin for Acute-Onset Obsessive-Compulsive Disorder in Children
    Celecoxib as Adjunctive Treatment in Acute Mania
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.